Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Jul
27
2020
 PTAB’S Motion To Amend Patentability Powers K&L Gates LLP
Jul
26
2020
 Beware! Inventors Include Those Who Significantly Contributed to a Claimed Invention – Even if their Contribution is Not Recited in the Claim Squire Patton Boggs (US) LLP
Jul
23
2020
 Independently Performed, Publicly Disclosed Prior Work Can Lead to Joint Inventorship McDermott Will & Emery
Jul
23
2020
 CAFC Affirms Decision to not Rescind ITC General Exclusion Order Based on New Invalidity Arguments Squire Patton Boggs (US) LLP
Jul
22
2020
 Joined Parties Have Rights Too McDermott Will & Emery
Jul
22
2020
 Third Parties Not Responsible for Defective Motion to Seal McDermott Will & Emery
Jul
22
2020
 Technical Issues Affirm Patent Validity but Preclude Pre-Suit Damages McDermott Will & Emery
Jul
17
2020
 In Assessing Design Patent Infringement, The Devil Is In The Details Squire Patton Boggs (US) LLP
Jul
16
2020
 Federal Circuit Confirms Addition of Two Inventors of Groundbreaking Immunotherapies for Cancer Sheppard, Mullin, Richter & Hampton LLP
Jul
15
2020
 Patent Owners Beware: Serial Filings, Rent-Seeking May Be Grounds for Adverse Fee Award McDermott Will & Emery
Jul
15
2020
 “All Substantial Rights” Test Informative in Obviousness-Type Double Patenting Context McDermott Will & Emery
Jul
15
2020
 Federal Circuit Extends Arthrex to Ex Parte Re-Examination Proceedings McDermott Will & Emery
Jul
14
2020
 The Bio/Pharma Beat July 2020 Squire Patton Boggs (US) LLP
Jul
13
2020
 Exclusive License Can Raise Obviousness-Type Double Patenting Issues Foley & Lardner LLP
Jul
9
2020
 The Standard May Rule Them All: Federal Circuit Panel Appears Prepared to Find Standard Is Sufficient to Prove Infringement for SEP Compliant Products Mintz
Jul
9
2020
 Lights Out for Light-Up Shoe Patent, Thanks to Non-Limiting Preamble McDermott Will & Emery
Jul
9
2020
 Reliance on Common Sense Permitted in Obviousness Analysis McDermott Will & Emery
Jul
8
2020
 “Seams” Like Activity Giving Rise to Infringement Risk Supports Appellate Jurisdiction McDermott Will & Emery
Jul
6
2020
 Filling the Hole with Common Sense: When Evidentiary Support is Adequate Mintz
Jun
30
2020
 Federal Circuit Focuses On Active Ingredient, Not Active Moiety, For Scope Of Patent Term Extension Foley & Lardner LLP
Jun
25
2020
 Google v. Oracle and the Future of Software Development Vedder Price
Jun
25
2020
 Federal Circuit Partially Rejects Appeal as Based on Non-Final Judgments McDermott Will & Emery
Jun
24
2020
 Non-Infringement Need Not “Be Actually Litigated” to Invoke Kessler Doctrine McDermott Will & Emery
Jun
23
2020
 The Federal Circuit Broadens Application of the Kessler Doctrine Mintz
Jun
23
2020
 USPTO Releases Final Rules on PTA Calculations in view of Supernus Mintz
Jun
17
2020
 Munchkin Is Luv-n This Win McDermott Will & Emery
Jun
11
2020
 Federal Circuit Confirms Certain Color Marks Can be Inherently Distinctive for Product Packaging Katten
Jun
10
2020
 Fee Shifting Under § 285 Does Not Apply to Conduct Solely Arising in IPR McDermott Will & Emery
Jun
5
2020
 Stuck at the PTAB – Expanding the Scope of Non-Appealable Institution Decisions McDermott Will & Emery
Jun
5
2020
 The Odyssey Must Be Timed Just Right McDermott Will & Emery
Jun
1
2020
 Illumina v. Ariosa – Fed. Cir. Splits a Fine s. 101 Hair Schwegman, Lundberg & Woessner, P.A.
May
29
2020
 USPTO Again Extends Certain Patent and Trademark Deadlines in Response to COVID-19 Squire Patton Boggs (US) LLP
May
28
2020
 Verdict Delivered: Shipment Notification Claims are Patent Ineligible—Even with Security Flair McDermott Will & Emery
May
27
2020
 USPTO Introduces Prioritized Examination Pilot Program for Patent Applications Related to COVID-19 Winstead
May
27
2020
 Chalk One Up to the Knock-Off McDermott Will & Emery
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters